News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
856,724 Results
Type
Article (87141)
Company Profile (704)
Press Release (768858)
Multimedia
Podcasts (160)
Webinars (24)
Section
Business (232941)
Career Advice (4136)
Deals (39774)
Drug Delivery (132)
Drug Development (91169)
Employer Resources (200)
FDA (18233)
Job Trends (17382)
News (397108)
Policy (39876)
Tag
Academia (3002)
Academic (2)
Accelerated approval (16)
Adcomms (33)
Allergies (111)
Alliances (56979)
ALS (129)
Alzheimer's disease (1631)
Antibody-drug conjugate (ADC) (197)
Approvals (18214)
Artificial intelligence (438)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (143)
Biotechnology (482)
Bladder cancer (111)
Brain cancer (45)
Breast cancer (425)
Cancer (3389)
Cardiovascular disease (286)
Career advice (3548)
Career pathing (34)
CAR-T (224)
CDC (43)
Cell therapy (614)
Cervical cancer (27)
Clinical research (74725)
Collaboration (1219)
Company closure (4)
Compensation (807)
Complete response letters (44)
COVID-19 (2929)
CRISPR (72)
C-suite (450)
Cystic fibrosis (128)
Data (3481)
Decentralized trials (2)
Denatured (57)
Depression (89)
Diabetes (397)
Diagnostics (7026)
Digital health (28)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (202)
Drug pricing (168)
Drug shortages (36)
Duchenne muscular dystrophy (175)
Earnings (98602)
Editorial (52)
Employer branding (25)
Employer resources (169)
Events (132085)
Executive appointments (941)
FDA (20373)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1087)
Gene editing (155)
Generative AI (43)
Gene therapy (483)
GLP-1 (977)
Government (5329)
Grass and pollen (7)
Guidances (328)
Healthcare (20933)
HIV (47)
Huntington's disease (32)
IgA nephropathy (50)
Immunology and inflammation (202)
Immuno-oncology (17)
Indications (44)
Infectious disease (3139)
Inflammatory bowel disease (173)
Inflation Reduction Act (13)
Influenza (83)
Intellectual property (150)
Interviews (814)
IPO (17916)
IRA (59)
Job creations (5195)
Job search strategy (2863)
Kidney cancer (15)
Labor market (66)
Layoffs (617)
Leadership (30)
Legal (10143)
Liver cancer (88)
Longevity (12)
Lung cancer (474)
Lymphoma (243)
Machine learning (17)
Management (65)
Manufacturing (523)
MASH (113)
Medical device (14799)
Medtech (14812)
Mergers & acquisitions (22651)
Metabolic disorders (1027)
Multiple sclerosis (109)
NASH (23)
Neurodegenerative disease (171)
Neuropsychiatric disorders (49)
Neuroscience (2474)
NextGen: Class of 2025 (7687)
Non-profit (5094)
Now hiring (54)
Obesity (520)
Opinion (300)
Ovarian cancer (110)
Pain (140)
Pancreatic cancer (139)
Parkinson's disease (210)
Partnered (27)
Patents (368)
Patient recruitment (231)
Peanut (55)
People (65943)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23044)
Phase II (32436)
Phase III (24437)
Pipeline (2347)
Policy (273)
Postmarket research (3554)
Preclinical (10403)
Press Release (72)
Prostate cancer (165)
Psychedelics (48)
Radiopharmaceuticals (279)
Rare diseases (579)
Real estate (7404)
Recruiting (76)
Regulatory (27544)
Reports (64)
Research institute (2668)
Resumes & cover letters (650)
Rett syndrome (11)
RNA editing (14)
RSV (62)
Schizophrenia (113)
Series A (180)
Series B (130)
Service/supplier (30)
Sickle cell disease (73)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4313)
State (2)
Stomach cancer (17)
Supply chain (89)
Tariffs (81)
The Weekly (101)
Vaccines (984)
Venture capital (63)
Weight loss (358)
Women's health (54)
Worklife (20)
Date
Today (21)
Last 7 days (600)
Last 30 days (2545)
Last 365 days (34024)
2025 (22263)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (75)
Alaska (7)
Arizona (290)
Arkansas (14)
Asia (50720)
Australia (8909)
California (8595)
Canada (2623)
China (802)
Colorado (365)
Connecticut (385)
Delaware (235)
Europe (116447)
Florida (1281)
Georgia (295)
Hawaii (3)
Idaho (67)
Illinois (775)
India (42)
Indiana (419)
Iowa (19)
Japan (255)
Kansas (120)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1188)
Massachusetts (6523)
Michigan (290)
Minnesota (529)
Mississippi (4)
Missouri (111)
Montana (32)
Nebraska (26)
Nevada (96)
New Hampshire (75)
New Jersey (2377)
New Mexico (31)
New York (2355)
North Carolina (1326)
North Dakota (10)
Northern California (3798)
Ohio (272)
Oklahoma (17)
Oregon (49)
Pennsylvania (1819)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (43)
South Dakota (1)
Southern California (3237)
Tennessee (138)
Texas (1347)
United States (32108)
Utah (256)
Virginia (233)
Washington D.C. (82)
Washington State (740)
West Virginia (4)
Wisconsin (90)
There are 856,724 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GLG Life Tech Corporation Reports 2025 Second Quarter Financial Results
September 1, 2025
·
22 min read
Press Releases
FDA Approval of Leqembi Subcutaneous Formulation Charts Path to Combination Therapies for Alzheimer’s Disease
September 1, 2025
·
3 min read
Press Releases
Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine
September 1, 2025
·
13 min read
Press Releases
Merck Provides New Results for VERQUVO® (vericiguat) in Patients with Chronic Heart Failure and Reduced Ejection Fraction
September 1, 2025
·
12 min read
Press Releases
Acoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality (CVM) through Month 42 of the ATTRibute-CM Open Label Extension
September 1, 2025
·
8 min read
Press Releases
New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
September 1, 2025
·
13 min read
Press Releases
Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension
September 1, 2025
·
14 min read
Press Releases
Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial
September 1, 2025
·
17 min read
Novartis Leqvio® shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain
September 1, 2025
·
11 min read
Press Releases
Baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control hypertension in the BaxHTN Phase III trial
September 1, 2025
·
12 min read
1 of 85,673
Next
